Danaher/DHR
$265.80
0.36%-
1D1W1MYTD1YMAX
About Danaher
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Ticker
DHR
Sector
Healthcare
Trading on
NYSE
Industry
Scientific & Technical Instr.
CEO
Steven Rales
Employees
61,000
Headquarters
Washington, United States
Website
www.danaher.com
Danaher Metrics
BasicAdvanced
$197B
Market cap
45.07
P/E ratio
$5.90
EPS
0.86
Beta
$1.05
Dividend rate
0.41%
Dividend yield
Price and volume
Market cap
$197B
Beta
0.8628
52-week high
$265.94
52-week low
$182.09
Average daily volume
2.6M
Dividend rate
$1.05
Financial strength
Current ratio
1.848
Quick ratio
1.508
Long term debt to equity
30.719
Total debt to equity
33.986
Dividend payout ratio (TTM)
19.07%
Enterprise value to free cash flow
51.096
Interest coverage (TTM)
21.68%
Management effectiveness
Return on assets (TTM)
4.83%
Return on equity (TTM)
7.88%
Return on investment (TTM)
5.36%
Valuation
Price to earnings (TTM)
45.069
Price to revenue (TTM)
8.294
Price to book
3.683
Price to free cash flow (TTM)
41.334
Five year average dividend yield
0.39%
Dividend yield (TTM)
0.4%
Forward dividend yield
0.41%
Growth
Revenue change (TTM)
-4.69%
Earnings per share change (TTM)
-30.21%
3-year revenue growth
2.35%
3-year earnings per share growth
4.98%
3-year dividend per share growth
14.29%
What the Analysts think about Danaher
Analyst Ratings
Majority rating from 26 analysts.
Price Targets
Average projection from 20 analysts.
High $297.00
Low $220.00
$265.80
Current price
$271.39
Average price target
Danaher Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$5.8B
-75.74%
Net income
$1.1B
-77.16%
Profit margin
18.77%
-5.87%
Danaher Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.05
$2.02
$2.09
$1.92
-
Expected
$2.01
$1.87
$1.91
$1.71
$1.58
Surprise
2.19%
8.28%
9.61%
12.29%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Danaher stock?
Danaher (DHR) has a market cap of $197B as of May 20, 2024.
What is the P/E ratio for Danaher stock?
The price to earnings (P/E) ratio for Danaher (DHR) stock is 45.07 as of May 20, 2024.
Does Danaher stock pay dividends?
Yes, the Danaher (DHR) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $1.05 and the yield is 0.41%. Danaher has a payout ratio of 19.07% on a trailing twelve-month basis.
When is the next Danaher dividend payment date?
The next Danaher (DHR) dividend payment is scheduled for July 26, 2024.
What is the beta indicator for Danaher?
Danaher (DHR) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Danaher stock price target?
The target price for Danaher (DHR) stock is $271.39, which is 2.1% above the current price of $265.8. This is an average based on projections from 20 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Danaher stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.